SEER · Seer, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.79M | - | $4.12M | $4.05M | $4.21M | - | $4.03M | $3.07M | $3.07M | - |
| Cost of Revenue | $1.81M | - | $2.01M | $1.94M | $2.14M | - | $2.09M | $1.34M | $1.71M | - |
| Gross Profit | $982.0K | - | $2.11M | $2.11M | $2.06M | - | $1.94M | $1.73M | $1.36M | - |
| R&D | $8.81M | - | $10.80M | $11.98M | $11.35M | - | $12.97M | $12.73M | $12.27M | - |
| SG&A | $9.43M | - | $10.66M | $10.66M | $11.44M | - | $13.30M | $16.07M | $14.29M | - |
| Total Operating Expenses | $18.24M | - | $21.46M | $22.64M | $22.79M | - | $26.26M | $28.83M | $26.55M | - |
| D&A | $1.16M | - | $1.48M | $1.46M | $1.44M | - | $1.60M | $1.50M | $1.50M | - |
| Operating Income | ($17.26M) | - | ($19.35M) | ($20.53M) | ($20.73M) | - | ($24.32M) | ($27.10M) | ($25.19M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $10.0K | - | $24.0K | $0 | $0 | - | - | - | - | - |
| Net Income | ($16.84M) | - | ($18.23M) | ($19.42M) | ($19.95M) | - | ($21.33M) | ($22.85M) | ($20.68M) | - |
| EPS - Basic | - | - | - | - | - | - | ($0.35) | ($0.35) | ($0.32) | - |
| EPS - Diluted | - | - | - | - | - | - | ($0.35) | ($0.35) | ($0.32) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47.32M | $47.28M | $44.97M | $37.93M | $52.45M | $40.75M | $37.62M | $31.95M | $54.40M | $32.50M |
| Accounts Receivable | - | - | - | - | - | - | - | - | $4.83M | - |
| Inventory | $8.08M | $7.79M | $8.13M | $7.51M | $7.07M | $7.44M | $6.93M | $7.58M | $5.81M | $4.49M |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $181.59M | $201.53M | $214.36M | $225.64M | $255.27M | $253.32M | $264.10M | $299.69M | $324.15M | $330.51M |
| Total Assets | $272.13M | $296.08M | $308.61M | $322.49M | $347.26M | $366.60M | $383.42M | $406.61M | $421.96M | $436.27M |
| Current Liabilities | $10.24M | $15.69M | $15.04M | $11.79M | $13.20M | $15.33M | $14.38M | $17.04M | $12.83M | $13.22M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $30.65M | $36.78M | $36.79M | $34.20M | $36.26M | $39.03M | $38.70M | $41.91M | $38.41M | $39.37M |
| Stockholders' Equity | $241.48M | $259.31M | $271.81M | $288.29M | $311.01M | $327.57M | $344.73M | $364.70M | $383.56M | $396.90M |
| Retained Earnings | ($482.81M) | ($465.97M) | ($449.98M) | ($431.74M) | ($412.32M) | ($392.37M) | ($370.63M) | ($349.30M) | ($326.45M) | ($305.77M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($15.44M) | - | - | - | ($11.42M) | - | - | - | ($10.46M) | - |
| Investing Cash Flow | $18.08M | - | - | - | $24.61M | - | - | - | $32.35M | - |
| Financing Cash Flow | ($2.61M) | - | - | - | ($1.50M) | - | - | - | $0 | - |
| CapEx | $270.0K | - | - | - | $654.0K | - | - | - | $754.0K | - |
| Free Cash Flow | ($15.71M) | - | - | - | ($12.07M) | - | - | - | ($11.21M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 35.2% | - | 51.2% | 52.1% | 49.0% | - | 48.1% | 56.3% | 44.4% | - |
| Operating margin | -617.8% | - | -469.4% | -506.8% | -493.0% | - | -603.3% | -882.0% | -821.7% | - |
| EBITDA margin | -576.4% | - | -433.6% | -470.8% | -458.9% | - | -563.6% | -833.2% | -772.7% | - |
| Net margin | -602.8% | - | -442.5% | -479.5% | -474.4% | - | -529.0% | -743.8% | -674.5% | - |
| Free cash flow margin | -562.3% | - | - | - | -287.1% | - | - | - | -365.6% | - |
| FCF / Net income | 0.93 | - | - | - | 0.61 | - | - | - | 0.54 | - |
| R&D / Revenue | 315.3% | - | 262.0% | 295.9% | 269.9% | - | 321.6% | 414.5% | 400.0% | - |
| SG&A / Revenue | 337.7% | - | 258.7% | 263.0% | 272.1% | - | 329.8% | 523.2% | 466.0% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -6.2% | - | -5.9% | -6.0% | -5.7% | - | -5.6% | -5.6% | -4.9% | - |
| Return on equity | -7.0% | - | -6.7% | -6.7% | -6.4% | - | -6.2% | -6.3% | -5.4% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 17.73 | 12.84 | 14.25 | 19.15 | 19.34 | 16.53 | 18.36 | 17.59 | 25.27 | 25.00 |
| Quick ratio | 16.94 | 12.35 | 13.71 | 18.51 | 18.81 | 16.04 | 17.88 | 17.15 | 24.81 | 24.66 |
| Cash ratio | 4.62 | 3.01 | 2.99 | 3.22 | 3.97 | 2.66 | 2.62 | 1.88 | 4.24 | 2.46 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.13 | 1.14 | 1.14 | 1.12 | 1.12 | 1.12 | 1.11 | 1.11 | 1.10 | 1.10 |
| Liabilities / Assets | 0.11 | 0.12 | 0.12 | 0.11 | 0.10 | 0.11 | 0.10 | 0.10 | 0.09 | 0.09 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - |
| Inventory turnover | 0.22 | - | 0.25 | 0.26 | 0.30 | - | 0.30 | 0.18 | 0.29 | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | 575d | - |
| Days inventory outstanding | 1628d | - | 1475d | 1413d | 1204d | - | 1209d | 2063d | 1244d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | 0.3x | 0.3x | 0.3x | - |
| P / S | - | - | - | - | - | - | 29.9x | 35.3x | 40.0x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -33.6% | - | 2.2% | 31.9% | 37.1% | - | -3.1% | -23.4% | -24.4% | - |
| Revenue CAGR (3y) | -11.7% | - | 1.4% | 3.8% | 8.3% | - | 23.2% | 251.1% | 158.7% | - |
| Revenue CAGR (5y) | 73.6% | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -52.4% | - | 8.9% | 22.0% | 51.4% | - | -10.1% | -24.1% | -34.2% | - |
| Operating income growth (YoY) | 16.8% | - | 20.5% | 24.2% | 17.7% | - | 5.9% | 3.0% | 8.2% | - |
| Net income growth (YoY) | 15.6% | - | 14.5% | 15.0% | 3.5% | - | -1.1% | 2.5% | 13.7% | - |
| EPS growth (YoY) | - | - | - | - | - | - | -6.1% | 5.4% | 15.8% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -30.1% | - | - | - | -7.7% | - | - | - | 42.4% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -22.4% | -20.8% | -21.2% | -21.0% | -18.9% | -17.5% | -15.0% | -12.8% | -11.4% | -11.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$15.82M totalProduct$11.21M · 70.9%
Service$4.15M · 26.2%
Other$459.0K · 2.9%
Peer comparison
Same SIC group: Laboratory Analytical Instruments
Comparing Seer against the 5 most active filers in the same SIC group.